The compound represented by the formula (I-1):
wherein all the symbols have the same meanings as described in the specification, has two cyclic groups, particularly phenoxy groups at specific substitution positions and thus has high human S1P
2
antagonistic activity. The compound may therefore be used as a therapeutic agent for S1P
2
-mediated diseases such as diseases resulting from vascular constriction, fibrosis and respiratory diseases.
化合物的
化学式为(I-1),其中所有符号的含义与说明书中描述的相同,该化合物具有两个环状基团,特别是在特定的取代位置上具有苯氧基团,因此具有高人体S1P2拮抗活性。因此,该化合物可用作S1P2介导疾病的治疗剂,例如由于血管收缩、纤维化和呼吸系统疾病引起的疾病。